高濃度のホモシステインと低濃度のEGFRが,脳卒中後の認知障害に及ぼす共同効果
Chunyan Zhang1, Xueqin Cao1, Chen Liu2
1Department of Neurology, Second Hospital, Shanxi Medical University, Taiyuan, China.
Frontiers in neurology
|August 20, 2025
まとめ
高濃度のホモシステインと腎臓機能の低下は,脳卒中後の認知障害のリスクを大幅に高めます. これは,脳卒中に関連した認知低下を予測する際に,高血糖糖血症と低推定球膜濾過率 (eGFR) の組み合わせによる影響を強調しています.
科学分野:
- 神経科学
- 腎臓科
- 心血管医学
背景:
- 血清ホモシステインレベルと脳卒中後の認知障害 (PSCI) の関連性は議論されている.
- この関係に対する腎機能の影響については,さらなる調査が必要である.
研究 の 目的:
- 血清ホモシステインレベルが独立してPSCIを予測するかどうかを判断する.
- ホモシステイン-PSCI関連性に対する腎機能の影響を評価する.
主な方法:
- 608人の不血性脳卒中患者の遡及分析
- ホモシステイン濃度と認知機能の評価 (MMSE,MoCA) 退院後1ヶ月
- 回帰分析と相互作用テストを用いた統計的評価
主要な成果:
- 高濃度のホモシステインはPSCIと相関しており,特に推定グルメルフィルタレーション率 (eGFR) が低い患者では特にそうであった.
- eGFRと認知スコア (MMSE,MoCA) の間に有意な相互作用が見つかりました.
- eGFR < 90 ml/ min/ 1. 73 m2 とホモシステイン≥ 15 μmol/ L の患者は,PSCIのリスクが著しく増加した.
結論:
- ハイパーホモシステイン血症とeGFRの低下は,PSCIの独立した予測因子である.
- 高ホモシステインと低EGFRの併用は,PSCIのリスクを大幅に高めます.
関連する概念動画
01:17Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260